Meeting News CoverageVideo

VIDEO: Cataract surgery safe in patients undergoing aflibercept therapy for DME

SAN FRANCISCO — At the American Society of Retina Specialists meeting here, OSN Retina/Vitreous Section Editor Andrew A. Moshfeghi, MD, MBA, of the USC Roski Eye Institute, discusses a study that found no impact on visual outcomes and nominal central retinal thickness gains when patients on aflibercept therapy for diabetic macular edema underwent cataract surgery.

SAN FRANCISCO — At the American Society of Retina Specialists meeting here, OSN Retina/Vitreous Section Editor Andrew A. Moshfeghi, MD, MBA, of the USC Roski Eye Institute, discusses a study that found no impact on visual outcomes and nominal central retinal thickness gains when patients on aflibercept therapy for diabetic macular edema underwent cataract surgery.

    See more from American Society of Retina Specialists Meeting